Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
TomaTech was an Israeli agtech seed company focused on developing hybrid tomato varieties for greenhouse and fresh-market production. The company combined molecular-marker technology with classical breeding to create tomatoes emphasizing flavor, yield, shelf life, plant performance, and resistance traits such as Tomato brown rugose fruit virus resistance. In 2022, TomaTech and Nirit Seeds were acquired and merged, and the combined business was later rebranded as Harmoniz. As a result, TomaTech is best understood today as a former standalone tomato seed company whose assets, breeding programs, and commercial operations now continue under Harmoniz.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on TomaTech.